Why does Pfizer believe older patients need another booster?
Updated: 5:06 PM EDT Mar 15, 2022
GOOD TO SEE YOU. >> YOU TOO. JESSICA: AS YOU KNOW, PELEOP WITH COMPROMISED IMMUNE SYSTEMS ARE ALREADY AUTHORIZED TO RECEIVE A SECOND BOOSTER. WHY DOES PFIZER THINK OLDER AMERICANS NEED ANOTHER SHOT O?TO >> WHAT IS HAPPENING, FIRST OF ALL THE FOURTH SHOT IS BEING EVEN IN A NUMBER OF COUNTRIES LIKE ISRAEL, FRAE,NC CHILE, GERMANY. SO IT IS BEING DONE IN MANY COMPANY — COUNTRIES BUT IT THE REAL — THE DATA IN ISRAEL WAS MIXED. THERE WAS AN INCREASE IN IMMUNITY BUT THAT WAS NO HIGHER THAN AFTER THE THIRD DOES. SO IT LOOKED LIKE YOU GIVE THE THIRD DOSE — FOURTH DOSE AND IT HELPS THE WINNING IMMUNITY YOU HAD PUT IT ESDO NOT BOOST IMMUNE SYSTEM ANY HIGHER. I THKIN OVERALL IN ALL LIKELIHOOD, THE FDA WILL GREENLIGHT THIS. BECAUSE WANING IMMUNITY, THE- FACT IS THE ELDERLY ARE MORE- VULNERABLE AND THERE ARE STILL VARIANTS, BA-2 IS SURGING IN THE U.K. AND WE MAY EXPECT IT HERE AS WELL AS IT CONTINUES TO RISE. I’M HOPEFUL THE FDA WILL GIVE LIFE BUT I DON’T THINK THE FUTURE WILL BE JUST BOOSTING EVERY FOUR OR FIVE MONTHS. THINK WE NEED TO GET TO THE NEXT GENERATION OF SCENES AND SEE IF THAT PROTESCT BETTER. MARIA: AND MONGER. YOU TRACK THE DATA CLOSE.LY ARE YOU SEEING ANY WARNING SIGNS FOR THAT AGE GROUP? >> THE GOOD NEWS IS THAT MOST PATIENTS WHO ARE BOOSTED ARE NOT COMING INTO THE HOSPITAL OR DYING OF COVID. DPH PUBLISHED GUIDANCE THAT SAID ONLY ABOUT 180 FULLY BOOSTED PEOPLE HAD DIED FROM THE VIRUS AND YOU KNOW IN MASSACHUSETTS WE’VE HAD TENS OF THOUSANDS OF PEOPLE DIE. THE BOOSTING SEEMS PROTECTIVE. WE DO OCCASIONALLY SEE ELDERLY AND IMMUNOCOMPROMISED PATIENTS WHO ARE BOOSTED SO GETTGIN HOSPITALIZED. HOWEVER –T I IS ANOTHER REINFORCEMENT THAT THE VIRUSS I UNCERTAIN AND NOT OVER. JESSICA: BASED ON EVERYTHING YOU HAVE SEEN, DO YOU THINK ALL ERAMICANS WILL NEED A SENDCO BOOSTER SHOT COMING IN THE FALL? >> THE ANSWER IS WE DON’T KNOW. WE WILL PROBABLY LOOK TOWARD THE SOUTHERN HEMISPHERE DURING THEIR WINTER TO E SEIF NEW VARIANTS P POUP. WE ARE WAITING TO SEE WHAT THE DECLINE IS. AFTER THE THIRD DOSE THERE IS STILL HIGH PROTECTION AGAINST HOSPITALIZATION AND ABOUT 91% AFTER TWO MONTHS, DROPPED TO ABOUT 78 PERCENT AFTER FOUR OR FIVE MONTHS. WE WILL HAVE TO SEE HOW THAT DROPS. THAT WILL FACTOR INTO THE FDA DECISION. I WOULD SAY ON AN ANNUAL LEVEL, PROBABLY VULNERABLE POPULATIONS, ELRLDEY AND IMMUNOCOMPROMISED, WILL LIKELY NEED ANNUAL BOOSTERS. BUTOR F THE YOUNG HEALTHY POPULATION IT REMAINS TO BE SEEN. MA
Advertisement
Why does Pfizer believe older patients need another booster?
Updated: 5:06 PM EDT Mar 15, 2022
Dr. Todd Ellerin, director of infectious diseases at South Shore Health, said he believes the FDA will approve Pfizer’s request.
Dr. Todd Ellerin, director of infectious diseases at South Shore Health, said he believes the FDA will approve Pfizer’s request.
Advertisement